NetSuite ERP for BioTech & Life Sciences

Phase 1: Discovery & Project Planning

We begin by understanding where you are today; clinical-stage, commercial-stage, or scaling between the two. We map processes, data flows, and regulatory touchpoints across:

• GL & sub-ledger architecture for biotech cost centers
• Clinical trial accounting
• Grant, NIH & milestone funding
• Multi-entity & global consolidation
• Inventory & controlled materials tracking
• Validation requirements (GxP-aligned where applicable)

This is where future audit trails, reporting rigor, and operational scalability are architected. You leave this stage with a clear timeline, scope, validated process flows, and a system blueprint that respects how life sciences finance teams think.

Phase 2: System Design & Configuration

NetSuite is configured to mirror your scientific and financial workflows not the other way around. Core configuration focuses on:

• Chart of accounts tailored to biotech R&D, COGS, and program tracking
• Department, project, program & cost-center structure for drug development
• Approval workflows aligned to FDA, SOX, and internal quality governance
• Purchasing controls for lab supplies, CMOs, CROs, and equipment
• Spend control and audit visibility
• Inventory, batch/lot, and controlled material records
• Fixed asset capitalization for lab build-out and equipment
• Grant reporting, deferred revenue, and milestone billing
• Multi-entity structures for subsidiaries, JV partners, and international entities

We build a compliant backbone that scales from seed-stage science startup to commercial manufacturer.

Phase 3: Data Migration

Data isn't just imported, it’s validated, auditable, and trustworthy. In the data migration phase, We migrate:

• Historical financials and trial balances
• Vendor, CMO, CRO, and supplier master data
• Historical purchase activity
• Inventory and lot data, if applicable
• Fixed asset records
• Costed program/project data

Controls implemented:

• Secure transfer & access protocols
• Reconciliation checks
• Standard validation rules
• Audit-ready documentation

In Biotech, trust in data isn’t optional. It’s how investors evaluate burn rate, auditors verify compliance, and leadership makes scientific investment decisions.

Phase 4: Testing & Validation

Testing isn’t just about “does it work.” It's about compliance, traceability, and operational continuity. We simulate:

• Financial close cycles for R&D companies
• Approval & procurement workflows for regulated environments
• Inventory traceability (lots, expiration, serialized items if applicable)
• Program & clinical cost tracking
• Budget vs actual reporting
• Revenue scenarios for milestone and licensing agreements
• Consolidation & multi-entity reporting
• Audit and SOX controls where needed
• CSV/EDI/API integrations (CROs, CMOs, QMS, LIMS, HRIS, Banks)

Issues are documented, remediated, retested, and signed off. The result: a system you can defend to auditors, board members, and regulators.

Phase 5: User Training & Change Enablement

Life sciences teams often come from Excel-heavy workflows or legacy unscalable ERP systems. Training ensures adoption and prevents “shadow systems.” We train all your team, with advanced training to your:

• Finance & accounting staff
• Lab operations and procurement teams
• Department heads and budget owners
• Executive leadership for dashboards & reporting

We focus on giving your finance team confidence and independence not eternal dependence on consultants.

Phase 6: Go-Live & Transition

Go-live is structured to avoid operational disruption, month-end chaos, or procurement bottlenecks. Support includes:

• Cut-over management
• Data validation & GL tie-outs
• Lab procurement continuity
• Month-end close support
• Vendor & PO readiness checks
• Spend control enforcement
• Inventory and asset validation (if in scope)

We don’t just turn on the system, we shepherd your team into a compliant, streamlined operating model.

Phase 7: Hyper-Care & Post-Implementation Support

Post go-live, your world changes fast audits, funding rounds, scaling headcount, maybe FDA inspections looming. Our Hyper-care Support typically covers:

• Close cycle assistance
• Dashboard refinement & KPI buildout
• Grant reporting optimization
• Additional approvals & internal controls
• CMO/CRO workflow enhancements
• Inventory tracking maturity for pre-commercial scale
• Integration updates (QMS, LIMS, banking, AP automation)
• Continuous improvement based on real-world usage

The metric isn't "system working." It's your finance engine functioning like a biotech finance engine should transparent burn rate, controlled spend, and defensible reporting.